BEAM logo

Beam Therapeutics Inc. (BEAM) Cash From Financing

Annual CFF:

$7.74M-$268.71M(-97.20%)
December 31, 2024

Summary

  • As of today, BEAM annual cash from financing is $7.74 million, with the most recent change of -$268.71 million (-97.20%) on December 31, 2024.
  • During the last 3 years, BEAM annual cash from financing has fallen by -$748.40 million (-98.98%).
  • BEAM annual cash from financing is now -98.98% below its all-time high of $756.14 million, reached on December 31, 2021.

Performance

1-Year Change

-97.2%

3-Year Change

-98.98%

5-Year Change

-81.26%

15-Year Change

+55.22%

BEAM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

49.04%
BEAM annual cash from financing is higher than 49.04% of companies in Healthcare sector

Range

All-Time High

$756.14M
BEAM annual cash from financing is currently -98.98% below its historical high of $756.14 million

3-Year Low

$7.74M
BEAM annual cash from financing is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
BEAM previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
BEAM next annual earnings announcement has not yet been scheduled

OtherBEAMcash flow metrics

Annual CFI

$185.01M
BEAM annual cash from investing is $185.01 million

Annual CFO

-$347.25M
BEAM annual cash from operations is -$347.25 million

Annual FCF

-$356.19M
BEAM annual free cash flow is -$356.19 million

Annual CAPEX

$8.95M
BEAM annual capital expenditures is $8.95 million

Quarterly CFF:

$1.11M-$472.27M(-99.77%)
June 30, 2025

Summary

  • As of today, BEAM quarterly cash from financing is $1.11 million, with the most recent change of -$472.27 million (-99.77%) on June 30, 2025.
  • Over the past year, BEAM quarterly cash from financing has increased by +$976.00 thousand (+733.83%).
  • BEAM quarterly cash from financing is now -99.77% below its all-time high of $473.38 million, reached on March 31, 2025.

Performance

3-Month Change

-99.77%

1-Year Change

+733.83%

3-Year Change

-95.04%

5-Year Change

+242.36%

BEAM Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

64.5%
BEAM quarterly cash from financing is higher than 64.5% of companies in Healthcare sector

Range

All-Time High

$473.38M
BEAM quarterly cash from financing is currently -99.77% below its historical high of $473.38 million

3-Year Low

$133.00K
BEAM quarterly cash from financing is currently +733.83% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
BEAM previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 4, 2025
BEAM next earnings announcement is scheduled for Nov 4, 2025

OtherBEAMcash flow metrics

Quarterly CFI

-$170.41M
BEAM quarterly cash from investing is -$170.41 million

Quarterly CFO

-$76.45M
BEAM quarterly cash from operations is -$76.45 million

Quarterly FCF

-$79.59M
BEAM quarterly free cash flow is -$79.59 million

Quarterly CAPEX

$3.14M
BEAM quarterly capital expenditures is $3.14 million

TTM CFF:

$479.19M+$976.00K(+0.20%)
June 30, 2025

Summary

  • As of today, BEAM TTM cash from financing is $479.19 million, with the most recent change of +$976.00 thousand (+0.20%) on June 30, 2025.
  • Over the past year, BEAM TTM cash from financing has increased by +$405.67 million (+551.79%).
  • BEAM TTM cash from financing is now -44.58% below its all-time high of $864.59 million, reached on September 30, 2021.

Performance

3-Month Change

+0.2%

1-Year Change

+551.79%

3-Year Change

+13.97%

5-Year Change

+148.25%

BEAM TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

98.57%
BEAM TTM cash from financing is higher than 98.57% of companies in Healthcare sector

Range

All-Time High

$864.59M
BEAM TTM cash from financing is currently -44.58% below its historical high of $864.59 million

3-Year Low

$7.74M
BEAM TTM cash from financing is currently +6094.34% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
BEAM previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 4, 2025
BEAM next earnings announcement is scheduled for Nov 4, 2025

OtherBEAMcash flow metrics

TTM CFI

-$144.52M
BEAM TTM cash from investing is -$144.52 million

TTM CFO

-$344.82M
BEAM TTM cash from operations is -$344.82 million

TTM FCF

-$355.57M
BEAM TTM free cash flow is -$355.57 million

TTM CAPEX

$10.75M
BEAM TTM capital expenditures is $10.75 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BEAM Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-97.2%+733.8%+551.8%
3Y3 Years-99.0%-95.0%+14.0%
5Y5 Years-81.3%+242.4%+148.3%

BEAM Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-99.0%at low-99.8%+733.8%at high+6094.3%
5Y5-Year-99.0%at low-99.8%+1079.8%-44.6%+6094.3%
All-TimeAll-Time-99.0%+55.2%-99.8%+242.4%-44.6%+6094.3%

BEAM Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.11M(-99.8%)
$479.19M(+0.2%)
Mar 2025
-
$473.38M(>+9900.0%)
$478.22M(+6081.7%)
Dec 2024
$7.74M(-97.2%)
$3.44M(+172.9%)
$7.74M(-79.6%)
Sep 2024
-
$1.26M(+848.9%)
$38.01M(-48.3%)
Jun 2024
-
$133.00K(-95.4%)
$73.52M(-59.4%)
Mar 2024
-
$2.90M(-91.4%)
$180.93M(-34.6%)
Dec 2023
$276.45M(+147.7%)
$33.71M(-8.3%)
$276.45M(+0.6%)
Sep 2023
-
$36.78M(-65.8%)
$274.75M(+14.7%)
Jun 2023
-
$107.54M(+9.3%)
$239.53M(+55.2%)
Mar 2023
-
$98.42M(+207.4%)
$154.33M(+38.3%)
Dec 2022
$111.59M(-85.2%)
$32.01M(+1949.4%)
$111.59M(+10.4%)
Sep 2022
-
$1.56M(-93.0%)
$101.12M(-75.9%)
Jun 2022
-
$22.34M(-59.9%)
$420.44M(-24.7%)
Mar 2022
-
$55.68M(+158.4%)
$558.54M(-26.1%)
DateAnnualQuarterlyTTM
Dec 2021
$756.14M(+134.6%)
$21.54M(-93.3%)
$756.14M(-12.5%)
Sep 2021
-
$320.89M(+100.0%)
$864.59M(+59.0%)
Jun 2021
-
$160.44M(-36.7%)
$543.80M(+42.1%)
Mar 2021
-
$253.27M(+94.8%)
$382.58M(+18.7%)
Dec 2020
$322.32M(+680.8%)
$129.99M(>+9900.0%)
$322.32M(+67.0%)
Sep 2020
-
$94.00K(+112.1%)
$193.03M(-1.3%)
Jun 2020
-
-$779.00K(-100.4%)
$195.63M(-0.4%)
Mar 2020
-
$193.01M(>+9900.0%)
$196.38M(+375.8%)
Dec 2019
$41.28M(-77.0%)
$699.00K(-74.0%)
$41.28M(-74.3%)
Sep 2019
-
$2.69M(>+9900.0%)
$160.65M(+1.7%)
Jun 2019
-
-$20.00K(-100.1%)
$157.96M(-0.0%)
Mar 2019
-
$37.91M(-68.4%)
$157.97M(+31.6%)
Dec 2018
$179.73M(+3506.1%)
$120.07M
$120.07M
Dec 2017
$4.98M
-
-

FAQ

  • What is Beam Therapeutics Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. annual cash from financing year-on-year change?
  • What is Beam Therapeutics Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. quarterly cash from financing year-on-year change?
  • What is Beam Therapeutics Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. TTM cash from financing year-on-year change?

What is Beam Therapeutics Inc. annual cash from financing?

The current annual cash from financing of BEAM is $7.74M

What is the all-time high annual cash from financing for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high annual cash from financing is $756.14M

What is Beam Therapeutics Inc. annual cash from financing year-on-year change?

Over the past year, BEAM annual cash from financing has changed by -$268.71M (-97.20%)

What is Beam Therapeutics Inc. quarterly cash from financing?

The current quarterly cash from financing of BEAM is $1.11M

What is the all-time high quarterly cash from financing for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high quarterly cash from financing is $473.38M

What is Beam Therapeutics Inc. quarterly cash from financing year-on-year change?

Over the past year, BEAM quarterly cash from financing has changed by +$976.00K (+733.83%)

What is Beam Therapeutics Inc. TTM cash from financing?

The current TTM cash from financing of BEAM is $479.19M

What is the all-time high TTM cash from financing for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high TTM cash from financing is $864.59M

What is Beam Therapeutics Inc. TTM cash from financing year-on-year change?

Over the past year, BEAM TTM cash from financing has changed by +$405.67M (+551.79%)
On this page